These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1139 related articles for article (PubMed ID: 11115404)
1. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. Lejeune D; Demoulin JB; Renauld JC Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742 [TBL] [Abstract][Full Text] [Related]
3. Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3). Magrangeas F; Boisteau O; Denis S; Jacques Y; Minvielle S Biochem J; 2001 Jan; 353(Pt 2):223-30. PubMed ID: 11139384 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Cacalano NA; Sanden D; Johnston JA Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873 [TBL] [Abstract][Full Text] [Related]
5. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo. Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496 [TBL] [Abstract][Full Text] [Related]
6. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells. Anderson P; Sundstedt A; Li L; O'Neill EJ; Li S; Wraith DC; Wang P Int Immunol; 2003 Nov; 15(11):1309-17. PubMed ID: 14565929 [TBL] [Abstract][Full Text] [Related]
7. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor. Dif F; Saunier E; Demeneix B; Kelly PA; Edery M Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228 [TBL] [Abstract][Full Text] [Related]
8. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells. Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961 [TBL] [Abstract][Full Text] [Related]
9. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. van de Geijn GJ; Gits J; Touw IP J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455 [TBL] [Abstract][Full Text] [Related]
10. A family of cytokine-inducible inhibitors of signalling. Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125 [TBL] [Abstract][Full Text] [Related]
11. The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells. Rønn SG; Hansen JA; Lindberg K; Karlsen AE; Billestrup N Mol Endocrinol; 2002 Sep; 16(9):2124-34. PubMed ID: 12198248 [TBL] [Abstract][Full Text] [Related]
12. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918 [TBL] [Abstract][Full Text] [Related]
13. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors. Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain. van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637 [TBL] [Abstract][Full Text] [Related]
15. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines. Colson A; Le Cam A; Maiter D; Edery M; Thissen JP Endocrinology; 2000 Oct; 141(10):3687-95. PubMed ID: 11014223 [TBL] [Abstract][Full Text] [Related]
17. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. Ram PA; Waxman DJ J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor. Demoulin JB; Van Snick J; Renauld JC Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517 [TBL] [Abstract][Full Text] [Related]
19. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646 [TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes. Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]